Segard

Segard Uses, Dosage, Side Effects, Food Interaction and all others data.

Segard (also known as Fab 2 or MAK 195F) is an anti-TNF-α monoclonal antibody. Administration of 195F reduces the concentration of interleukin-6 in patients with sepsis.

Segard is the F(ab')2 fragment of a murine anti-TNF-alpha antibody, and has been evaluated in clinical trials in septic patients. The results suggest that the drug is well tolerated, and may be of benefit in certain groups of patients with sepsis. Segard is safe, biologically active, and well tolerated in patients with severe sepsis, reduces 28-day all-cause mortality, and attenuates the severity of organ dysfunction in patients with elevated interleukin-6 levels.

Trade Name Segard
Generic Afelimomab
Afelimomab Other Names Afelimomab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Segard
Segard

Uses

Investigated for use/treatment in sepsis and septicemia.

Half Life

44.7 hours

Innovators Monograph

You find simplified version here Segard

*** Taking medicines without doctor's advice can cause long-term problems.
Share